RecruitingNCT06307262
European Registry of Transcatheter Repair for Tricuspid Regurgitation
European Registry of Transcatheter Repair for Tricuspid Regurgitation (EuroTR)
Sponsor
LMU Klinikum
Enrollment
3,000 participants
Start Date
Oct 23, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
To investigate clinical and survival outcomes following transcatheter tricuspid valve repair or replacement.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Patients treated with one of the following transcatheter devices for TV repair or replacement: PASCAL, TriClip, TricValve, Evoque, LuX-Valve
- Age ≥ 18 years
Interventions
DEVICET-TEER
T-TEER using the PACAL or TriClip device
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06307262
Related Trials
Mind Your Heart-II
NCT054311921 location
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288652 locations
ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
NCT071917301 location
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370641 locations
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT0700216420 locations